Attached files
file | filename |
---|---|
10-Q/A - AMENDMENT NO. 1 - ACURA PHARMACEUTICALS, INC | v431764_10qa.htm |
EX-31.2 - EXHIBIT 31.2 - ACURA PHARMACEUTICALS, INC | v431764_ex31-2.htm |
EX-10.1 - EXHIBIT 10.1 - ACURA PHARMACEUTICALS, INC | v431764_ex10-1.htm |
Exhibit 31.1
CERTIFICATION OF PERIODIC REPORT PURSUANT TO RULES 13a-14 AND 15d-14
OF THE SECURITIES EXCHANGE ACT OF 1934
I, Robert B. Jones, the President & Chief Executive Officer of Acura Pharmaceuticals, Inc., certify that:
1. | I have reviewed this amendment to the quarterly report on Form 10-Q of Acura Pharmaceuticals, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
February 16, 2016 | /s/ Robert B. Jones | |
Robert B. Jones President & Chief Executive Officer |